NCT01854437已完成不适用
The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- plasma phosphate level
研究概览
简要总结
Hyperphosphatemia is a common problem in hemodialysis (HD) patients. Different chelators for control of Hyperphosphatemia are used. The aim of this study was to assess the effect of magnesium oxide (Mg Oxide) on the control of serum phosphorus (P) level and evaluation of its side effects in hemodialysis patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •hemodialysis with duration>3 months serum P level >5.5 mg/dl serum Ca>8 mg/dl.
排除标准
- •Mg level >3 mg/dl
研究组 & 干预措施
Mg Oxide
Mg Oxide (Mg®, 21st Century®) 250 mg orally for 4 weeks
干预措施: Mg Oxide (Drug)
结局指标
主要结局
plasma phosphate level
时间窗: 4 week
次要结局
未报告次要终点
研究者
Maryam Pakfetrat
associated professor of shiraz Shiraz University of Medical Sciences
Shiraz University of Medical Sciences
研究点 (1)
Loading locations...
相似试验
招募中
不适用
MAGnesium in Chronic HemoDialysisNL-OMON23476VU University Medical Center53
进行中（未招募）
不适用
Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag)Kidney DiseasesEnd-Stage Kidney DiseaseHemodialysisNCT04079582London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's25,000
已完成
不适用
Potassium Flux in Hemodialysis PatientsHemodialysisNCT04287010Washington University School of Medicine25
招募中
不适用
MAGnesium In Chronic HemoDialysis; A clinical trial assessing the feasibility of increasing plasma magnesium concentrations by means of increasing dialysate magnesium concentrations in chronic hemodialysis patients.kidney diseaseNL-OMON48731Vrije Universiteit Medisch Centrum53
Unknown
不适用
a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis PatientsChronic Kidney Disease Requiring Chronic DialysisNCT04600193University of Copenhagen21